首页> 外国专利> ACTIVE INGREDIENT DELIVERY SYSTEM FOR EXTENDING IN-VIVO HALF-LIFE OF ACTIVE INGREDIENT

ACTIVE INGREDIENT DELIVERY SYSTEM FOR EXTENDING IN-VIVO HALF-LIFE OF ACTIVE INGREDIENT

机译:扩展活性成分体内半衰期的活性成分递送系统

摘要

Disclosed is an active ingredient delivery system for extending an in-vivo half-line of an active ingredient. The active ingredient delivery system comprises carrier peptide and the conjugate of the active ingredient. The conjugate has a serum half-line which is extended compared to the peculiar serum half-line of the active ingredient, the carrier peptide is a peptide bonded to albumin in blood in order to extend the serum half-line of the active ingredient. The carrier peptide is a peptide including sequence number 1, a peptide having a sequence homogeny of 80% or more with the peptide sequence, or a fragment of the same. The peptide having a sequence homogeny of 80% or more and the fragment may have a serum albumin bonding function of the sequence number 1 peptide. Using the techniques disclosed in the present invention, an in-vivo half-line of an active ingredient can be extended, and the administered amount and the number of administrations of the active ingredient can be reduced, so that the effects of the active ingredient can be improved.;COPYRIGHT KIPO 2014
机译:公开了一种用于扩展活性成分的体内半线的活性成分输送系统。活性成分递送系统包含载体肽和活性成分的缀合物。缀合物具有与活性成分的特殊血清半线相比延长的血清半线,载体肽是与血液中的白蛋白结合的肽,以延长活性成分的血清半线。载体肽是包括序列号1的肽,与该肽序列具有80%或更高的序列同源性的肽或其片段。具有80%或更高的序列同源性的肽,并且所述片段可以具有序列号为1的肽的血清白蛋白结合功能。使用本发明公开的技术,可以延长活性成分的体内半线,并且可以减少活性成分的给药量和给药次数,从而可以有效地发挥作用。加以改进。; COPYRIGHT KIPO 2014

著录项

  • 公开/公告号KR20140103544A

    专利类型

  • 公开/公告日2014-08-27

    原文格式PDF

  • 申请/专利权人 KAEL-GEMVAX CO. LTD.;KIM SANG JAE;

    申请/专利号KR20130017045

  • 发明设计人 KIM SANG JAEKR;

    申请日2013-02-18

  • 分类号A61K47/42;C07K7/08;C07K14/47;

  • 国家 KR

  • 入库时间 2022-08-21 15:42:14

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号